Adaptive Biotechnologies
Price & Volume
Stats
See moreOpen | $15.22 |
Previous Close | $15.19 |
Day Range | $15.13-$15.58 |
52W Range | $9.07-$20.76 |
Market Cap | $2.2B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $295.4M |
Revenue Growth (YoY) | 35.1% |
Gross Profit (12 Mos) | $129.1M |
Diluted EPS | -$0.32 |
News
See moreYahoo Finance • last month
Adaptive Biotechnologies' COO Is Running a Systematic Sell Program — Here's What It Means
Yahoo Finance • last month
Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares?
Yahoo Finance • 2 months ago
Mid-cap healthcare stocks with A grade EPS revisions ahead of earnings
Yahoo Finance • 2 months ago
Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On
About
CEO | Mr. Chad M. Robins M.B.A. |
CFO | Mr. Kyle Piskel |
Address | 1165 Eastlake Avenue East, Seattle, WA, United States, 98109 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 624 |